Click for best price
Hepatitis Vaccine Market Size, Share 2023
Hepatitis vaccine is a vaccine that prevents hepatitis
This report aims to provide a comprehensive presentation of the global market for Hepatitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Vaccine. This report contains market size and forecasts of Hepatitis Vaccine in global, including the following market information:
Global Hepatitis Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Hepatitis Vaccine Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Hepatitis Vaccine companies in 2022 (%)
The global Hepatitis Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Hepatitis A Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hepatitis Vaccine include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences and Serum Institute, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Hepatitis Vaccine Market Segment Percentages, by Type, 2022 (%)
Hepatitis A Vaccines
Hepatitis B Vaccines
Global Hepatitis Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Hepatitis Vaccine Market Segment Percentages, by Application, 2022 (%)
Children
Adult
Global Hepatitis Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Hepatitis Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis Vaccine revenues share in global market, 2022 (%)
Key companies Hepatitis Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hepatitis Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Sanofi
Sinovac
Zhejiang Pukang
IMBCA
ChangSheng
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis Vaccine, market overview.
Chapter 2: Global Hepatitis Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Hepatitis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hepatitis Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hepatitis Vaccine Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis Vaccine Overall Market Size
2.1 Global Hepatitis Vaccine Market Size: 2022 VS 2030
2.2 Global Hepatitis Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Hepatitis Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Hepatitis Vaccine Players in Global Market
3.2 Top Global Hepatitis Vaccine Companies Ranked by Revenue
3.3 Global Hepatitis Vaccine Revenue by Companies
3.4 Global Hepatitis Vaccine Sales by Companies
3.5 Global Hepatitis Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis Vaccine Market Size Markets, 2022 & 2030
4.1.2 Hepatitis A Vaccines
4.1.3 Hepatitis B Vaccines
4.2 By Type - Global Hepatitis Vaccine Revenue & Forecasts
4.2.1 By Type - Global Hepatitis Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Hepatitis Vaccine Revenue Market Share, 2018-2030
4.3 By Type - Global Hepatitis Vaccine Sales & Forecasts
4.3.1 By Type - Global Hepatitis Vaccine Sales, 2018-2023
4.3.2 By Type - Global Hepatitis Vaccine Sales, 2024-2030
4.3.3 By Type - Global Hepatitis Vaccine Sales Market Share, 2018-2030
4.4 By Type - Global Hepatitis Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis Vaccine Market Size, 2022 & 2030
5.1.2 Children
5.1.3 Adult
5.2 By Application - Global Hepatitis Vaccine Revenue & Forecasts
5.2.1 By Application - Global Hepatitis Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Hepatitis Vaccine Revenue Market Share, 2018-2030
5.3 By Application - Global Hepatitis Vaccine Sales & Forecasts
5.3.1 By Application - Global Hepatitis Vaccine Sales, 2018-2023
5.3.2 By Application - Global Hepatitis Vaccine Sales, 2024-2030
5.3.3 By Application - Global Hepatitis Vaccine Sales Market Share, 2018-2030
5.4 By Application - Global Hepatitis Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Hepatitis Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Hepatitis Vaccine Revenue & Forecasts
6.2.1 By Region - Global Hepatitis Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Hepatitis Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Hepatitis Vaccine Sales & Forecasts
6.3.1 By Region - Global Hepatitis Vaccine Sales, 2018-2023
6.3.2 By Region - Global Hepatitis Vaccine Sales, 2024-2030
6.3.3 By Region - Global Hepatitis Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Hepatitis Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Hepatitis Vaccine Sales, 2018-2030
6.4.3 US Hepatitis Vaccine Market Size, 2018-2030
6.4.4 Canada Hepatitis Vaccine Market Size, 2018-2030
6.4.5 Mexico Hepatitis Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Hepatitis Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Hepatitis Vaccine Sales, 2018-2030
6.5.3 Germany Hepatitis Vaccine Market Size, 2018-2030
6.5.4 France Hepatitis Vaccine Market Size, 2018-2030
6.5.5 U.K. Hepatitis Vaccine Market Size, 2018-2030
6.5.6 Italy Hepatitis Vaccine Market Size, 2018-2030
6.5.7 Russia Hepatitis Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Hepatitis Vaccine Market Size, 2018-2030
6.5.9 Benelux Hepatitis Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Hepatitis Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Hepatitis Vaccine Sales, 2018-2030
6.6.3 China Hepatitis Vaccine Market Size, 2018-2030
6.6.4 Japan Hepatitis Vaccine Market Size, 2018-2030
6.6.5 South Korea Hepatitis Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Hepatitis Vaccine Market Size, 2018-2030
6.6.7 India Hepatitis Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Hepatitis Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Hepatitis Vaccine Sales, 2018-2030
6.7.3 Brazil Hepatitis Vaccine Market Size, 2018-2030
6.7.4 Argentina Hepatitis Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Hepatitis Vaccine Sales, 2018-2030
6.8.3 Turkey Hepatitis Vaccine Market Size, 2018-2030
6.8.4 Israel Hepatitis Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Hepatitis Vaccine Market Size, 2018-2030
6.8.6 UAE Hepatitis Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis Vaccine Major Product Offerings
7.1.4 GSK Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 NCPC
7.2.1 NCPC Company Summary
7.2.2 NCPC Business Overview
7.2.3 NCPC Hepatitis Vaccine Major Product Offerings
7.2.4 NCPC Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 NCPC Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Hepatitis Vaccine Major Product Offerings
7.3.4 Merck Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Bio Kangtai
7.4.1 Bio Kangtai Company Summary
7.4.2 Bio Kangtai Business Overview
7.4.3 Bio Kangtai Hepatitis Vaccine Major Product Offerings
7.4.4 Bio Kangtai Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Bio Kangtai Key News & Latest Developments
7.5 Dynavax
7.5.1 Dynavax Company Summary
7.5.2 Dynavax Business Overview
7.5.3 Dynavax Hepatitis Vaccine Major Product Offerings
7.5.4 Dynavax Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Dynavax Key News & Latest Developments
7.6 Hissen
7.6.1 Hissen Company Summary
7.6.2 Hissen Business Overview
7.6.3 Hissen Hepatitis Vaccine Major Product Offerings
7.6.4 Hissen Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Hissen Key News & Latest Developments
7.7 KM Biologics
7.7.1 KM Biologics Company Summary
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis Vaccine Major Product Offerings
7.7.4 KM Biologics Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 KM Biologics Key News & Latest Developments
7.8 LG Life Sciences
7.8.1 LG Life Sciences Company Summary
7.8.2 LG Life Sciences Business Overview
7.8.3 LG Life Sciences Hepatitis Vaccine Major Product Offerings
7.8.4 LG Life Sciences Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 LG Life Sciences Key News & Latest Developments
7.9 Serum Institute
7.9.1 Serum Institute Company Summary
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Hepatitis Vaccine Major Product Offerings
7.9.4 Serum Institute Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Serum Institute Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Hepatitis Vaccine Major Product Offerings
7.10.4 Sanofi Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Sinovac
7.11.1 Sinovac Company Summary
7.11.2 Sinovac Hepatitis Vaccine Business Overview
7.11.3 Sinovac Hepatitis Vaccine Major Product Offerings
7.11.4 Sinovac Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Sinovac Key News & Latest Developments
7.12 Zhejiang Pukang
7.12.1 Zhejiang Pukang Company Summary
7.12.2 Zhejiang Pukang Hepatitis Vaccine Business Overview
7.12.3 Zhejiang Pukang Hepatitis Vaccine Major Product Offerings
7.12.4 Zhejiang Pukang Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Zhejiang Pukang Key News & Latest Developments
7.13 IMBCA
7.13.1 IMBCA Company Summary
7.13.2 IMBCA Hepatitis Vaccine Business Overview
7.13.3 IMBCA Hepatitis Vaccine Major Product Offerings
7.13.4 IMBCA Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 IMBCA Key News & Latest Developments
7.14 ChangSheng
7.14.1 ChangSheng Company Summary
7.14.2 ChangSheng Business Overview
7.14.3 ChangSheng Hepatitis Vaccine Major Product Offerings
7.14.4 ChangSheng Hepatitis Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 ChangSheng Key News & Latest Developments
8 Global Hepatitis Vaccine Production Capacity, Analysis
8.1 Global Hepatitis Vaccine Production Capacity, 2018-2030
8.2 Hepatitis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis Vaccine Supply Chain Analysis
10.1 Hepatitis Vaccine Industry Value Chain
10.2 Hepatitis Vaccine Upstream Market
10.3 Hepatitis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hepatitis Vaccine in Global Market
Table 2. Top Hepatitis Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatitis Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatitis Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Hepatitis Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Hepatitis Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatitis Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Hepatitis Vaccine Product Type
Table 9. List of Global Tier 1 Hepatitis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Hepatitis Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatitis Vaccine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Hepatitis Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Hepatitis Vaccine Sales (K Units), 2024-2030
Table 16. By Application ? Global Hepatitis Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Hepatitis Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatitis Vaccine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Hepatitis Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Hepatitis Vaccine Sales (K Units), 2024-2030
Table 21. By Region ? Global Hepatitis Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Hepatitis Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatitis Vaccine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Hepatitis Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Hepatitis Vaccine Sales (K Units), 2024-2030
Table 26. By Country - North America Hepatitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatitis Vaccine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Hepatitis Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Hepatitis Vaccine Sales, (K Units), 2024-2030
Table 30. By Country - Europe Hepatitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatitis Vaccine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Hepatitis Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Hepatitis Vaccine Sales, (K Units), 2024-2030
Table 34. By Region - Asia Hepatitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatitis Vaccine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Hepatitis Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Hepatitis Vaccine Sales, (K Units), 2024-2030
Table 38. By Country - South America Hepatitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatitis Vaccine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Hepatitis Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Hepatitis Vaccine Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Hepatitis Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatitis Vaccine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Hepatitis Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Hepatitis Vaccine Sales, (K Units), 2024-2030
Table 46. GSK Company Summary
Table 47. GSK Hepatitis Vaccine Product Offerings
Table 48. GSK Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. GSK Key News & Latest Developments
Table 50. NCPC Company Summary
Table 51. NCPC Hepatitis Vaccine Product Offerings
Table 52. NCPC Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. NCPC Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Hepatitis Vaccine Product Offerings
Table 56. Merck Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Bio Kangtai Company Summary
Table 59. Bio Kangtai Hepatitis Vaccine Product Offerings
Table 60. Bio Kangtai Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Bio Kangtai Key News & Latest Developments
Table 62. Dynavax Company Summary
Table 63. Dynavax Hepatitis Vaccine Product Offerings
Table 64. Dynavax Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Dynavax Key News & Latest Developments
Table 66. Hissen Company Summary
Table 67. Hissen Hepatitis Vaccine Product Offerings
Table 68. Hissen Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hissen Key News & Latest Developments
Table 70. KM Biologics Company Summary
Table 71. KM Biologics Hepatitis Vaccine Product Offerings
Table 72. KM Biologics Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. KM Biologics Key News & Latest Developments
Table 74. LG Life Sciences Company Summary
Table 75. LG Life Sciences Hepatitis Vaccine Product Offerings
Table 76. LG Life Sciences Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. LG Life Sciences Key News & Latest Developments
Table 78. Serum Institute Company Summary
Table 79. Serum Institute Hepatitis Vaccine Product Offerings
Table 80. Serum Institute Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Serum Institute Key News & Latest Developments
Table 82. Sanofi Company Summary
Table 83. Sanofi Hepatitis Vaccine Product Offerings
Table 84. Sanofi Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Sanofi Key News & Latest Developments
Table 86. Sinovac Company Summary
Table 87. Sinovac Hepatitis Vaccine Product Offerings
Table 88. Sinovac Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Sinovac Key News & Latest Developments
Table 90. Zhejiang Pukang Company Summary
Table 91. Zhejiang Pukang Hepatitis Vaccine Product Offerings
Table 92. Zhejiang Pukang Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Zhejiang Pukang Key News & Latest Developments
Table 94. IMBCA Company Summary
Table 95. IMBCA Hepatitis Vaccine Product Offerings
Table 96. IMBCA Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. IMBCA Key News & Latest Developments
Table 98. ChangSheng Company Summary
Table 99. ChangSheng Hepatitis Vaccine Product Offerings
Table 100. ChangSheng Hepatitis Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. ChangSheng Key News & Latest Developments
Table 102. Hepatitis Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Hepatitis Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Hepatitis Vaccine Production by Region, 2018-2023 (K Units)
Table 105. Global Hepatitis Vaccine Production by Region, 2024-2030 (K Units)
Table 106. Hepatitis Vaccine Market Opportunities & Trends in Global Market
Table 107. Hepatitis Vaccine Market Drivers in Global Market
Table 108. Hepatitis Vaccine Market Restraints in Global Market
Table 109. Hepatitis Vaccine Raw Materials
Table 110. Hepatitis Vaccine Raw Materials Suppliers in Global Market
Table 111. Typical Hepatitis Vaccine Downstream
Table 112. Hepatitis Vaccine Downstream Clients in Global Market
Table 113. Hepatitis Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis Vaccine Segment by Type in 2022
Figure 2. Hepatitis Vaccine Segment by Application in 2022
Figure 3. Global Hepatitis Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hepatitis Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Hepatitis Vaccine Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis Vaccine Revenue in 2022
Figure 9. By Type - Global Hepatitis Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 12. By Type - Global Hepatitis Vaccine Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Hepatitis Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 16. By Application - Global Hepatitis Vaccine Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Hepatitis Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Hepatitis Vaccine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 21. By Country - North America Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 23. US Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 28. Germany Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. France Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 37. China Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. India Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 44. Brazil Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Hepatitis Vaccine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Hepatitis Vaccine Sales Market Share, 2018-2030
Figure 48. Turkey Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Hepatitis Vaccine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Hepatitis Vaccine Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Hepatitis Vaccine by Region, 2022 VS 2030
Figure 54. Hepatitis Vaccine Industry Value Chain
Figure 55. Marketing Channels
